Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Blood Adv
; 7(22): 7141-7150, 2023 11 28.
Article
in En
| MEDLINE
| ID: mdl-37722354
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Follicular
/
Lymphoma, B-Cell, Marginal Zone
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Type:
Article